The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...
Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...
March 10 (UPI) --The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate deficiency, a rare disorder. The vitamin, a synthetic form of ...
The Food and Drug Administration approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children. The move comes months ...
Share on Pinterest More research is still needed before leucovorin should be approved as an autism treatment. Westend61/Getty Images Federal regulators have approved leucovorin for the treatment of ...
The folinic acid supplement will be prescribed for a subset of children with autism who have “cerebral folate deficiency,” but experts caution, “it’s not a cure" Semi / Alamy Stock Photo F.D.A. issued ...
At a press conference in late 2025, federal officials made some big claims about leucovorin, a prescription drug usually reserved for people on cancer chemotherapy. "We're going to change the label to ...
The FDA made waves with its recent announcement that a single well-controlled Phase 3 study would suffice for a drug submission, replacing the previous standard of two pivotal studies. This past week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results